2022 Gastroenterology and Hepatology Symposium

Bringing together top thought-leaders in hepatology, inflammatory bowel disease, advanced endoscopy, and motility innovation, clinical care and research.

Join top thought-leaders in gastroenterology and hepatology clinical care and research for an engaging virtual online symposium focusing on advances in the multidisciplinary approach and innovative treatment options of gastrointestinal and liver disorders.

When: 8:00 a.m. - 5:05 p.m., Saturday, April 23rd, 2022

Where: Online symposium

8.25 AMA PRA Category 1 Credits Available

Register Now

+

Find out more

Agenda

Henry Ford Health System Gastroenterology and Hepatology Symposium- April 23, 2022

8:00 - 8:05 Welcome and Introduction (Kimberly Brown, M.D.)

Section I: Updates in Motility

8:05 – 8:10 Introduction of Section I Speakers and Section Overview of Objectives (Eva Alsheik, MD)

8:10 – 8:50 Innovation in gastrointestinal motility (Eric Shah, MD)

8:50 – 9:10 SIBO, IMO, or NBD? A Clinical Update on the Diagnosis and Treatment of Bacteria Overgrowth (Brian Ginnebaugh, MD)

9:10 – 9:30 Approach to defecatory disorders (Susanne Shokoohi, MD)

9:30 – 9:50 Interactive case discussion (Fellows: Stephen Simmer, MD, Jessica Jou, MD; Moderator: Eva Alsheik, MD)

Section II: Updates in Inflammatory Bowel Disease

9:50 – 9:55 Introduction of Section II Speakers and Section Overview of Objectives (Jason Schairer, MD)

9:55 – 10:35 IBD Keynote: Evaluation and management of strictures in IBD (Aline Charabaty, MD)

10:35 – 10:55 Endoscopic management of strictures in the age of Interventional IBD (Jason Schairer, MD)

10:55 – 11:15 Updates in the medical treatment and future therapies in IBD (Nirmal Kaur, MD)

11:15 – 12:15 Interactive case discussion, followed by joint Section I and II Panel Discussion and Q&A

(Fellow: Vivek Mendiratta, MD, Moderators: Eva Alsheik, MD, Jason Schairer, MD)

12:15 – 1:00 BREAK: Optional break out rooms with individual Section II speakers and Sponsors

Section III: Updates in Hepatology

1:00 – 1:05 Introduction of Section III Speakers and Section Overview of Objectives (Reena Salgia, MD)

1:05 – 1:45 Hepatology Keynote Speaker: Progress in the treatment of HBV: Can we visualize cure? (Ray Chung, MD)

1:45 – 2:05 NASH Therapies: the latest on how to treat the patient in your office (Humberto Gonzalez, MD)

2:05 – 2:25 CAM and the Liver: what’s safe, what’s not, and should we be recommending Milk Thistle (Syed-Mohammed Jafri, MD)

2:25 – 2:45 Interactive case discussion (Fellow: Suraj Suresh, MD, Moderator: Reena Salgia, MD)

Section IV: Updates In Advanced GI

2:45 – 2:50 Introduction of Section IV Speakers and Section Overview of Objectives (Eva Alsheik, MD)

2:50 – 3:30 Advanced Keynote Speaker: A Current Approach to Management of Pancreatic Fluid Collections (Joseph Elmunzer, MD)

3:30 – 3:50 Updates in PSC and cholangiocarcinoma (Sumit Singla, MD)

3:50 – 4:10 Barrett’s Esophagus: dysplasia update (Cyrus Piraka, MD)

4:10 – 4:55 Interactive case discussion followed by joint Section III and IV Panel Discussion and Q & A (Fellow: Sarah Russell, MD, Moderators: Kimberly Brown, MD, Reena Salgia, MD)

4:55 – 5:05 – Closing Remarks (Eva Alsheik, MD)

Agenda

Objectives

At the conclusion of this activity, learners will be able to:

To learn the latest advances in the treatment of Chronic Hepatitis B.
To understand the latest management strategies for non-alcoholic fatty liver disease (NAFLD/NASH).
To gain perspective on the role and safety of complementary and alternative medicine for liver disease.
Review diagnosis and management of IBD related strictures
To understand the updates in the medical treatments and future therapies in IBD.
To understand the latest innovations in gastrointestinal motility.
To learn about the approach to defecatory disorders.
To gain insight about the management of pancreatic fluid collections.
To review updates in Barrett's esophagus, PSC, SIBO and cholangiocarcinoma.